Beyond cardiovascular medicine: potential future uses of icosapent ethyl

Abstract. The REDUCE-IT trial demonstrated that icosapent ethyl, an ethyl ester of eicosapentaenoic acid (EPA), reduced cardiovascular events in an at-risk pop

Read the full article here

Related Articles